| Tiffany Yin Wong Chang, MD | |
|
25 N Winfield Rd, Winfield, IL 60190-1222 | |
| (630) 933-2048 | |
| Not Available |
| Full Name | Tiffany Yin Wong Chang |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 22 Years |
| Location | 25 N Winfield Rd, Winfield, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396915021 | NPI | - | NPPES |
| 036112863 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 036112863 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Dupage Hospital | Winfield, IL | Hospital |
| Delnor Community Hospital | Geneva, IL | Hospital |
| Kishwaukee Community Hospital | Dekalb, IL | Hospital |
| Northwestern Memorial Hospital | Chicago, IL | Hospital |
| Northwestern Medicine Mchenry Hospital | Mchenry, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Winfield Pathology Consultants, S.c. | 9931101102 | 11 |
News Archive
N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR).
A University of Colorado Cancer Center study recently published in the Journal of Hospital Medicine validates a prognostic tool that determines risk of death within a year of hospital admission, helping doctors match treatments to patients' values and goals of care.
JournalGuide - a free tool created by Research Square to help researchers choose the best journal for their manuscript - has added a new designation to its database to help authors identify the most reputable publishing options.
Unauthorized immigrants pay billions more into Medicare's Hospital Insurance Trust Fund each year than they withdraw in health benefits, according to research from Harvard Medical School, the Institute for Community Health and the City University of New York School of Public Health at Hunter College.
› Verified 2 days ago
| Entity Name | Winfield Pathology Consultants, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528147071 PECOS PAC ID: 9931101102 Enrollment ID: O20070201000371 |
News Archive
N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR).
A University of Colorado Cancer Center study recently published in the Journal of Hospital Medicine validates a prognostic tool that determines risk of death within a year of hospital admission, helping doctors match treatments to patients' values and goals of care.
JournalGuide - a free tool created by Research Square to help researchers choose the best journal for their manuscript - has added a new designation to its database to help authors identify the most reputable publishing options.
Unauthorized immigrants pay billions more into Medicare's Hospital Insurance Trust Fund each year than they withdraw in health benefits, according to research from Harvard Medical School, the Institute for Community Health and the City University of New York School of Public Health at Hunter College.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Yin Wong Chang, MD Department 4432, Carol Stream, IL 60122-0001 Ph: () - | Tiffany Yin Wong Chang, MD 25 N Winfield Rd, Winfield, IL 60190-1222 Ph: (630) 933-2048 |
News Archive
N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR).
A University of Colorado Cancer Center study recently published in the Journal of Hospital Medicine validates a prognostic tool that determines risk of death within a year of hospital admission, helping doctors match treatments to patients' values and goals of care.
JournalGuide - a free tool created by Research Square to help researchers choose the best journal for their manuscript - has added a new designation to its database to help authors identify the most reputable publishing options.
Unauthorized immigrants pay billions more into Medicare's Hospital Insurance Trust Fund each year than they withdraw in health benefits, according to research from Harvard Medical School, the Institute for Community Health and the City University of New York School of Public Health at Hunter College.
› Verified 2 days ago
Beth L Johnson, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Road, Winfield, IL 60190 Phone: 630-933-2048 | |
Stephanie M Sitterding, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-2048 | |
Sonya S Clifford, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-2048 | |
Dr. Ajay Jitendra Patel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-2636 | |
Philip C Mehaffey, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Road, Winfield, IL 60190 Phone: 630-933-2048 | |
Lawrence Ariano, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 25 N Winfield Road, Winfield, IL 60190 Phone: 630-933-2048 |